Lu, Minglei
Liang, Minting
Pan, Junkang
Zhong, Yingying
Zhang, Chunguo
Cui, Xiping
Wang, Tiantian
Yan, Jinfeng
Ding, Jinlong
Zhao, Suqing https://orcid.org/0000-0002-8458-671X
Funding for this research was provided by:
Guangzhou Science and Technology Foundation (201902010430100011, 201911845027)
Guangzhou Science and Technology Foundation (2016201604030025, 201903010034)
Guangdong Science and Technology Foundation (2017A050501034, 2018A030313926)
Science and Technology Foundation Key R&D Program of Guangdong Province (2019B020209009, 2019B020218009)
R&D Program of Guangdong Province Drug Administration (2021TDZ09, 2021YDZ06)
Article History
Received: 6 July 2020
Accepted: 3 October 2021
First Online: 17 October 2021
Declarations
:
: This article does not contain any studies with human subjects. Code of ethics (the Guangdong Animal Center guidelines) for all animal experiments with regard to preparing antibodies were performed.
: Not applicable.
: Minglei Lu declares that he/she has no conflict of interest. Minting Liang declares that he/she has no conflict of interest. Junkang Pan declares that he/she has no conflict of interest. Yingying Zhong declares that he/she has no conflict of interest. Chunguo Zhang declares that he/she has no conflict of interest. Xiping Cui declares that he/she has no conflict of interest. Tiantian Wang declares that he/she has no conflict of interest. Jinfeng Yan declares that he/she has no conflict of interest. Jinlong Ding declares that he/she has no conflict of interest. Suqing Zhao declares that he/she has no conflict of interest.